TP63 and squamous cell lung carcinoma: This was also true in the tumor collection series GSE2109, in which the p63-silencing signature was positively associated with primary tumors of non-stratified epithelial tissues (e.g., breast) relative to tumors arising from stratified squamous epithelium (e.g., esophagus) or squamous cell carcinoma of the lung.